Influenza Vaccine Current Events | Influenza Vaccine News | 11
|
| Page
11 of
45 |
886 Results |
|
|
|
Sort By:
Page Views | Date |
Traditional Chinese exercises may increase efficacy of flu vaccine
Move on mosquitoes. Step aside sweat bees. Before long, another unwelcome, but predictable, pest will return: the dreaded, oft-spotted flu bug. view more (2007-08-14)
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily... view more... (2008-08-28)
College students who feel 'invincible' unlikely to accept vaccines, MU researcher finds
Vaccines to protect against sexually transmitted diseases, including HIV and herpes, are being developed and may soon be available to college students. view more (2009-07-30)
PROMISING RESULTS FOR MALARIA VACCINE (p 1927)
Results of a study from The Gambia in this week's issue of THE LANCET provide evidence of a vaccine that could prevent malaria caused by the micro-organism Plasmodium falciparum. P. falciparum malaria remains a major cause of disease and death in many parts of the tropics, especially in sub-Saharan Africa. The development of an effective vaccine... view more... (2001-12-05)
Map predicting spread of avian flu
The 2003 epidemic of Highly Pathogenic Avian Influenza (HPAI) in the Netherlands is the only recent epidemic of HPAI in the developed world. view more (2007-04-19)
Novel approach for rapid identification and development of malaria vaccines
Malaria is the world's most frequent parasitic disease, affecting more than 100 countries in the tropical zones, mostly in Africa, and 40% of the world population, with more than a million deaths per year. view more (2007-07-25)
New MUHC study adds more evidence to clear measles mumps rubella vaccine as a risk factor for autism
A new MUHC study provides conclusive evidence that the Measles Mumps Rubella (MMR) vaccine is not associated with the development of autism spectrum disorders (ASDs). view more (2006-10-18)
UNC, Harvard develop inhaled TB vaccine
A new tuberculosis vaccine successfully tested at the University of North Carolina at Chapel Hill is easier to administer and store and just as effective as one commonly used worldwide. view more (2008-03-17)
University Hospitals Case Medical Center and Case Western Reserve University School of Medicine to Conduct Innovative Smallpox Vaccine Research Study
University Hospitals Case Medical Center (UHCMC) and Case Western Reserve University School of Medicine are part of a nationwide research study to determine the safety and effectiveness of a new smallpox vaccine geared toward adults ages 18 to 34 who have never been vaccinated against the disease. view more (2007-06-04)
Pregnant women at high risk of complications from H1N1 influenza
With the H1N1 flu outbreak now elevated to pandemic level, a new article in CMAJ (Canadian Medical Association Journal) reports that oseltamivir (Tamiflu®) and zanamivir (Relenza®) are relatively safe drugs for use in pregnant and breast-feeding women. view more (2009-06-16)
Rapid response was crucial to containing the 1918 flu pandemic
One of the persistent riddles of the deadly 1918 Spanish influenza pandemic is why it struck different cities with varying severity. Why were some municipalities such as St. Louis spared the fate of the hard-hit cities like Philadelphia when both implemented similar public health measures? view more (2007-04-03)
Vaccine provides 100 percent protection against avian flu virus in animal study
University of Pittsburgh researchers announced they have genetically engineered an avian flu vaccine from the critical components of the deadly H5N1 virus that completely protected mice and chickens from infection. view more (2006-01-27)
New 3-D structural model of critical H1N1 protein developed
In just two weeks from the time the first patient virus samples were made available, Singapore scientists report an evolutionary analysis of a critical protein produced by the 2009 H1N1 influenza A virus strain. view more (2009-05-26)
Flu pandemic in prison
When pandemics occur, correctional facilities are not immune. With more than 9 million people incarcerated across the globe 2.25 million in U.S. jails and prisons alone it is vital that correctional officials and health professionals be prepared for a worst-case scenario that involves pandemic influenza reaching inmates and staff. view more (2009-05-06)
Critical illness from 2009 H1N1 in Mexico associated with high fatality rate
Critical illness from 2009 influenza A(H1N1) in Mexico occurred among young patients, was associated with severe acute respiratory distress syndrome and shock, and had a fatality rate of about 40 percent. view more (2009-10-13)
Johns Hopkins flu expert calls for mandatory vaccination of health care workers
Johns Hopkins' senior hospital epidemiologist and flu expert is calling for mandatory vaccination of all health care workers as the best means of protecting patients and hospital staff from widespread outbreaks of the viral illness. view more (2005-11-10)
More than half of Texas physicians do not always recommend HPV vaccine to girls
The Advisory Committee on Immunization Practices recommends the human papillomavirus vaccination for all 11- and 12-year-old girls, but results of a recent survey showed that more than half of Texas physicians do not follow these recommendations. view more (2009-08-06)
Most H1N1 patients with respiratory failure treated with oxygenating system survive illness
Despite the severity of disease and the intensity of treatment, most patients in Australia and New Zealand who experienced respiratory failure as a result of 2009 influenza A(H1N1) and were treated with a system that adds oxygen to the patient's blood survived the disease. view more (2009-10-13)
Encouraging Results For Long-Term Efficacy Of Meningitis C Vaccine
Four-year results assessing the efficacy of the UK meningitis C vaccine programme are reported in a research letter in this week's issue of THE LANCET. The vaccine is now showing long-term efficacy, except for infants initially vaccinated younger than 5 months of age. The meningococcal serogroup C conjugate (MCC) vaccine programme was introduced... view more... (2004-07-21)
New study suggests potential for a broadly-protective HIV vaccine
New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus. view more (2007-05-30)
|
|
| Page
11 of
45 |
886 Results |
|
|
|
Sort By:
Page Views | Date |
|
